abzyme_gr

E-vaccine has the potential to prevent HIV infection or to treat humans infected with HIV. The Abzyme Research Foundation's mission is to facilitate scientific and medical collaborations among leaders in the HIV field drawn from non-profit and for-profit organizations... READ MORE

Current News & Articles

Special Recent Posts

Interview With New Board Member Dr. Elizabeth Miller

Interview With New Board Member Dr. Elizabeth Miller

Q: To start with, tell me about your current work at Mount Sinai. A: I work in the field of therape[...]
2013 Annual Report

2013 Annual Report

2013 was a fantastic year for the Abzyme Research Foundation and our research partners Covalent Bi[...]
Progress Towards A Human Trial

Progress Towards A Human Trial

Explore the research and developmental steps of the HIV vaccine approach created by Dr. Sudhir Paul [...]
Meet Our New Board Members

Meet Our New Board Members

Fresh Perspectives Abzyme Research Foundation is proud to announce two new board members. Brian De[...]
Our FDA Pre-IND Date is 4/2/14

Our FDA Pre-IND Date is 4/2/14

Do you know what it takes to get a new HIV vaccine into human trials?  The process involves scientis[...]